190 related articles for article (PubMed ID: 25144777)
1. The liver in pediatric gastrointestinal disease.
Vo HD; Xu J; Rabinowitz SS; Fisher SE; Schwarz SM
J Pediatr Gastroenterol Nutr; 2014 Sep; 59(3):288-99. PubMed ID: 25144777
[TBL] [Abstract][Full Text] [Related]
2. Hepatic Complications of Inflammatory Bowel Disease.
Mahfouz M; Martin P; Carrion AF
Clin Liver Dis; 2019 May; 23(2):191-208. PubMed ID: 30947871
[TBL] [Abstract][Full Text] [Related]
3. Primary sclerosing cholangitis.
Geonzon-Gonzales MR
Gastroenterol Nurs; 2007; 30(2):102-5; quiz 105-7. PubMed ID: 17440311
[TBL] [Abstract][Full Text] [Related]
4. Hepatic manifestations of gastrointestinal diseases. Inflammatory bowel disease, celiac disease, and Whipple's disease.
Smyth C; Kelleher D; Keeling PW
Clin Liver Dis; 2002 Nov; 6(4):1013-32. PubMed ID: 12516204
[TBL] [Abstract][Full Text] [Related]
5. The liver in celiac disease.
Rubio-Tapia A; Murray JA
Hepatology; 2007 Nov; 46(5):1650-8. PubMed ID: 17969053
[TBL] [Abstract][Full Text] [Related]
6. Recent insights in primary sclerosing cholangitis.
Ponsioen CY
J Dig Dis; 2012 Jul; 13(7):337-41. PubMed ID: 22713082
[TBL] [Abstract][Full Text] [Related]
7. [Primary biliary cirrhosis. Primary sclerosing cholangitis].
Corpechot C; Chazouilleres O
Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 1):325-32. PubMed ID: 12769103
[No Abstract] [Full Text] [Related]
8. ACG Clinical Guideline: Primary Sclerosing Cholangitis.
Lindor KD; Kowdley KV; Harrison ME;
Am J Gastroenterol; 2015 May; 110(5):646-59; quiz 660. PubMed ID: 25869391
[TBL] [Abstract][Full Text] [Related]
9. Advances in primary sclerosing cholangitis.
Horsley-Silva JL; Carey EJ; Lindor KD
Lancet Gastroenterol Hepatol; 2016 Sep; 1(1):68-77. PubMed ID: 28404115
[TBL] [Abstract][Full Text] [Related]
10. Ursodeoxycholic acid therapy in cystic fibrosis liver disease--a retrospective long-term follow-up case-control study.
Kappler M; Espach C; Schweiger-Kabesch A; Lang T; Hartl D; Hector A; Glasmacher C; Griese M
Aliment Pharmacol Ther; 2012 Aug; 36(3):266-73. PubMed ID: 22670841
[TBL] [Abstract][Full Text] [Related]
11. Liver failure unmasks celiac disease in a child.
Al-Hussaini A; Basheer A; Czaja AJ
Ann Hepatol; 2013; 12(3):501-5. PubMed ID: 23619270
[TBL] [Abstract][Full Text] [Related]
12. Novel developments in IBD-related sclerosing cholangitis.
Ponsioen CY
Best Pract Res Clin Gastroenterol; 2011 Apr; 25 Suppl 1():S15-8. PubMed ID: 21640925
[TBL] [Abstract][Full Text] [Related]
13. Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.
Rojas-Feria M; Castro M; Suárez E; Ampuero J; Romero-Gómez M
World J Gastroenterol; 2013 Nov; 19(42):7327-40. PubMed ID: 24259964
[TBL] [Abstract][Full Text] [Related]
14. Ursodeoxycholic acid treatment in patients with cystic fibrosis at risk for liver disease.
Siano M; De Gregorio F; Boggia B; Sepe A; Ferri P; Buonpensiero P; Di Pasqua A; Raia V
Dig Liver Dis; 2010 Jun; 42(6):428-31. PubMed ID: 20034860
[TBL] [Abstract][Full Text] [Related]
15. Hepatic Manifestations of Cystic Fibrosis.
Sakiani S; Kleiner DE; Heller T; Koh C
Clin Liver Dis; 2019 May; 23(2):263-277. PubMed ID: 30947876
[TBL] [Abstract][Full Text] [Related]
16. [Cholestatic liver diseases: diagnosis and therapy of primary sclerosing cholangitis].
Opitz OG; Thimme R; Kreisel W
Dtsch Med Wochenschr; 2002 Sep; 127(36):1827-30. PubMed ID: 12215927
[No Abstract] [Full Text] [Related]
17. Delayed intestinal visualization at hepatobiliary scintigraphy is associated with response to long-term treatment with ursodeoxycholic acid in patients with cystic fibrosis-associated liver disease.
Colombo C; Crosignani A; Battezzati PM; Castellani MR; Comi S; Melzi ML; Giunta A
J Hepatol; 1999 Oct; 31(4):672-7. PubMed ID: 10551391
[TBL] [Abstract][Full Text] [Related]
18. Hepatobiliary complications of inflammatory bowel disease: overview of the issues.
Balistreri WF
Inflamm Bowel Dis; 1998 Aug; 4(3):220-4. PubMed ID: 9741026
[No Abstract] [Full Text] [Related]
19. [Cholestasis: therapeutic options].
Beuers U; Oswald M
Ther Umsch; 1998 Feb; 55(2):97-103. PubMed ID: 9545851
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic approaches for hepatobiliary disorders with ursodeoxycholic acid and bile-acid derivatives.
Serfaty L; Poupon R
Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S1. PubMed ID: 23141887
[No Abstract] [Full Text] [Related]
[Next] [New Search]
